| Levora Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Levora 30 mcg-0.15 mg | tablet | oral | 1.0 each | OTC |
| Levora 30 mcg-0.15 mg | tablet | oral | 1.0 each | OTC |
Posted by sylkountz69 5 months ago
sore nipples!
Posted by monkeybride 10 months ago
I gained 15 pounds while I was on Levora for 6 months. I'm trying to find a yet lower dosage pill, but in the meantime would ...
Posted by rjw123 11 months ago
I was on ortho-cept for a year and was retaining water so badly and my legs were swollen to the point that I could push down ...
Church Briefs Dec. 22, 2007 - Northeast Mississippi Daily Journal
Elder Levora Davis is the host pastor. n Women of Worship (WOW), a Christian women's fellowship group, will meet for its Fifth Sunday breakfast, ...
Sat Dec 22 08:29:29 -0500 2007
Church Briefs Dec. 22, 2007 - Northeast Mississippi Daily Journal
Elder Levora Davis is the host pastor. n Women of Worship (WOW), a Christian women's fellowship group, will meet for its Fifth Sunday breakfast, ...
Sat Dec 22 08:29:29 -0500 2007
Dog park to be resubmitted to the board - Crossville Chronicle
Ron Levora of the Long Range Planning committee updated several items on the committee's plate. • After an article regarding the desire for a dog park ...
Wed Nov 28 18:55:32 -0500 2007
ethinyl estradiol - A semisynthetic estrogen. Ethinyl estradiol binds to the estrogen receptor complex and enters the nucleus, activating DNA transcription of genes involved in estrogenic cellular responses. This agent also inhibits 5-alpha reductase in epididymal tissue, which lowers testosterone levels and may delay progression of prostatic cancer. In addition to its antineoplastic effects, ethinyl estradiol protects against osteoporosis. In animal models, short-term therapy with this agent has been shown to provide long-term protection against breast cancer, mimicking the antitumor effects of pregnancy. (NCI04)
levonorgestrel - The levorotatory form of norgestrel and synthetic progestogen with progestational and androgenic activity. Levonorgestrel binds to the progesterone receptor in the nucleus of target cells, thereby stimulating the resulting hormone-receptor complex, initiating transcription, and increasing the synthesis of certain proteins. This results in a suppression of luteinizing hormone (LH) activity and an inhibition of ovulation, as well as an alteration in the cervical mucus and endometrium.